Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3.1M
1 round on record
Latest round
$3.1M
Venture round · Oct 2025 · 12 mo ago
Team
11-50
employees, estimated range
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 $3.1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Chirality Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Arielle GabalskiExecutive Officer, DirectorSEC Form D
Joanna EagleExecutive OfficerSEC Form D

Overview

Chirality Biosciences is accelerating the course of humanity by building a world where life-saving drugs don’t come with a lifetime of compromises. We’re a pharmaceutical manufacturing company building next-generation chiral separation technology.

People

Arielle Gabalski
Executive Officer, Director
Joanna Eagle
Executive Officer
Robert Kayton
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Farmingdale United States
HQ
10-50 est. staff

Financials

Total raised
$3.1M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $3.1M Details